Stock Research for RGEN


Featured Broker: Ally Invest

Get the due diligence for another stock.


RGEN Stock Chart & Research Data

The RGEN chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the RGEN chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


RGEN Due diligence Resources & Stock Charts

The RGEN stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View RGEN Detailed Price Forecast - CNN Money CNN View RGEN Detailed Summary - Google Finance
Yahoo View RGEN Detailed Summary - Yahoo! Finance Zacks View RGEN Stock Research & Analysis -

Stock Analysis

TradeIdeas View RGEN Trends & Analysis - Trade-Ideas Barrons View RGEN Major Holders - Barrons
NASDAQ View RGEN Call Transcripts - NASDAQ Seeking View RGEN Breaking News & Analysis - Seeking Alpha
Spotlight View RGEN Annual Report - OTC Report View RGEN OTC Short Report -
TradeKing View RGEN Fundamentals - TradeKing Charts View RGEN SEC Filings - Bar Chart
WSJ View Historical Prices for RGEN - The WSJ Morningstar View Performance/Total Return for RGEN - Morningstar
MarketWatch View the Analyst Estimates for RGEN - MarketWatch CNBC View the Earnings History for RGEN - CNBC
StockMarketWatch View the RGEN Earnings - StockMarketWatch MacroAxis View RGEN Buy or Sell Recommendations - MacroAxis
Bullish View the RGEN Bullish Patterns - American Bulls Short Pains View RGEN Short Pain Metrics -

Social Media Mentions

StockTwits View RGEN Stock Mentions - StockTwits PennyStocks View RGEN Stock Mentions - PennyStockTweets
Twitter View RGEN Stock Mentions - Twitter Invest Hub View RGEN Investment Forum News - Investor Hub
Yahoo View RGEN Stock Mentions - Yahoo! Message Board Seeking Alpha View RGEN Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for RGEN - Insider Cow View Insider Transactions for RGEN - Insider Cow
CNBC View RGEN Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for RGEN - OTC Markets
Yahoo View Insider Transactions for RGEN - Yahoo! Finance NASDAQ View Institutional Holdings for RGEN - NASDAQ

Stock Charts

FinViz View RGEN Stock Insight & Charts - StockCharts View RGEN Investment Charts -
BarChart View RGEN Stock Overview & Charts - BarChart Trading View View RGEN User Generated Charts - Trading View

Latest Financial News for RGEN

See what the IHS Markit Score report has to say about Repligen Corp.
Posted on Thursday June 28, 2018

This means that investors who seek to profit from falling equity prices are currently targeting RGEN. Over the last month, growth of ETFs holding RGEN is favorable, with net inflows of $9.18 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing.

Purolite Life Sciences Announces the Launch of Praesto® Jetted A50 Using Proprietary Jetting Technology - Leading the Future of Protein A Chromatography Resins
Posted on Thursday June 28, 2018

In multiple successive trials, Praesto® Jetted A50 has consistently shown significantly improved performance over today's market leading Protein A resins, due to the unique benefits of an innovative new ligand coupled to a novel jetted base matrix.

Repligen Selects Purolite Life Sciences as Commercial Partner for New High Performance Ligand
Posted on Thursday June 28, 2018

Repligen Corporation (RGEN), a life sciences company focused on bioprocessing technology leadership, today announced it has entered into an agreement with Purolite Life Sciences to supply its next-generation Protein A ligand, NGL-Impact™ A,  which will be commercialized by Purolite Life Sciences using their novel Praesto® agarose jetting base bead technology. Repligen is a longtime market leader in Protein A, with two facilities that produce the majority of the global Protein A ligand demand to biopharmaceutical customers worldwide. NGL-Impact™ A was developed as part of Repligen’s collaboration with Navigo Proteins GmbH.

Repligen Announces Agreement with Navigo Proteins for the Exclusive Co-Development of Next Generation Affinity Ligands
Posted on Wednesday June 27, 2018

Repligen Corporation (RGEN), a life sciences company focused on bioprocessing technology leadership, today announced an agreement with Navigo Proteins GmbH (“Navigo”) for the advancement of exclusive novel affinity ligands used in monoclonal antibody (mAb) and non-mAb downstream purification processes. Under the terms of this agreement, Repligen and Navigo will co-develop a portfolio of next generation ligands, utilizing Navigo’s proprietary Precision Capturing™ technology platform.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.